Mia's Feed
Medical News & Research

Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs

Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs

Share this article

New research shows that youthful immune cells derived from stem cells can reverse signs of brain aging and improve memory in mouse models, promising potential therapies for neurodegenerative diseases.

2 min read

Researchers at Cedars-Sinai Medical Center have discovered that 'young' immune cells, generated from human stem cells, can reverse signs of aging and neurodegeneration in the brains of laboratory mice. Published in the journal Advanced Science, this preclinical study highlights the potential of harnessing immune cell therapy to combat cognitive decline associated with aging and Alzheimer's disease.

The study focused on mononuclear phagocytes—immune cells responsible for clearing harmful substances from the body, which typically decline in effectiveness with age. Scientists used pluripotent stem cells, which are adult cells reverted to an early embryonic state, to produce youthful versions of these immune cells. When infused into aging mice or models of Alzheimer’s, these cells produced notable improvements.

Mice treated with these young immune cells demonstrated better memory performance in behavioral tests and showed increased numbers of mossy cells in the hippocampus—a critical region for learning and memory. Additionally, the microglia, which act as the brain’s resident immune cells, remained healthier with more extensive branching, indicating preserved function.

Interestingly, the young immune cells did not appear to directly enter the brain, suggesting their beneficial effects might be mediated through indirect mechanisms, such as releasing protective proteins or extracellular vesicles into the bloodstream that influence brain health.

This research opens the door for developing personalized immune cell therapies from stem cells, offering an unlimited source of treatment candidates. The findings suggest that short-term interventions with these cells could significantly improve cognition and neural health, paving the way for future clinical trials in humans.

The study's authors believe that such therapies could provide promising new strategies for addressing age-related cognitive decline and neurodegenerative diseases like Alzheimer’s, by restoring immune function and brain health.

For more details, see the original publication in Advanced Science: DOI: 10.1002/advs.202417848.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Pulsed Low Dose Rate Chemoradiation Significantly Lowers Side Effects in Cancer Treatment

A cutting-edge pulsed low dose rate chemoradiation therapy has shown promise in reducing side effects for esophageal and lung cancer patients, maintaining treatment effectiveness while improving patient comfort.

Stopping HIV/AIDS Programs Could Lead to a 49% Rise in New Infections by 2030, Study Warns

A new study warns that ending federal funding for HIV/AIDS programs in the U.S. could lead to a 49% rise in new infections by 2030, emphasizing the importance of sustained support for prevention and treatment efforts.

Study Reveals Severe Economic Impact of Chronic Lung Disease in Kenya

A new study reveals that over a quarter of adults with symptoms of chronic lung disease in Kenya face catastrophic health costs, emphasizing the need for improved health insurance coverage.

Increase in Gut-Brain Interaction Disorders Post-Pandemic

A new study reports a rise in disorders of the gut-brain axis following the COVID-19 pandemic, emphasizing the need for enhanced healthcare strategies. Source: https://medicalxpress.com/news/2025-08-prevalence-disorders-gut-brain-interaction.html